THC vs. BMY
THC (Tenet Healthcare Corporation) and BMY (Bristol-Myers Squibb Company) are both stocks. Both are in the Healthcare sector — THC in Medical Care Facilities, BMY in Drug Manufacturers - General. Over the past 10 years, THC returned 20.25%/yr vs 1.00%/yr for BMY. At a 0.24 correlation, their price movements are largely independent.
Performance
THC vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THC achieves a -12.11% return, which is significantly lower than BMY's 8.27% return. Over the past 10 years, THC has outperformed BMY with an annualized return of 20.25%, while BMY has yielded a comparatively lower 1.00% annualized return.
THC
- 1D
- 0.86%
- 1M
- -12.03%
- YTD
- -12.11%
- 6M
- -12.41%
- 1Y
- 6.26%
- 3Y*
- 32.22%
- 5Y*
- 20.49%
- 10Y*
- 20.25%
BMY
- 1D
- 0.40%
- 1M
- 0.63%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
THC vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
THC Tenet Healthcare Corporation | -12.11% | 57.43% | 67.04% | 54.89% | -40.27% | 104.58% | 5.00% | 121.88% | 13.06% | 2.16% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between THC and BMY is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 1982 | 0.24 |
Over the past year, the correlation between THC and BMY has dropped to 0.03 - well below their long-term average of 0.24, suggesting their price drivers have been diverging.
Fundamentals
THC:
$15.30B
BMY:
$116.75B
THC:
$21.43
BMY:
$3.57
THC:
8.15
BMY:
16.02
THC:
0.08
BMY:
0.91
THC:
0.72
BMY:
2.40
THC:
3.18
BMY:
5.82
THC:
$21.46B
BMY:
$48.48B
THC:
$12.91B
BMY:
$33.33B
THC:
$4.00B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THC vs. BMY — Risk / Return Rank
THC
BMY
THC vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tenet Healthcare Corporation (THC) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| THC | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.54 | ||
| Sortino ratioReturn per unit of downside risk | -0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.14 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | 1.53 | -1.37 |
| Martin ratioReturn relative to average drawdown | 0.41 | 3.32 | -2.91 |
Loading charts...
Drawdowns
THC vs. BMY - Drawdown Comparison
The maximum THC drawdown since its inception was -98.28%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for THC and BMY.
Loading charts...
Drawdown Indicators
| THC | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -72.03% | -26.25% |
Max Drawdown (1Y)Largest decline over 1 year | -34.08% | -12.05% | -22.03% |
Max Drawdown (3Y)Largest decline over 3 years | -36.90% | -36.85% | -0.05% |
Max Drawdown (5Y)Largest decline over 5 years | -58.88% | -47.67% | -11.21% |
Max Drawdown (10Y)Largest decline over 10 years | -71.68% | -47.67% | -24.01% |
Current DrawdownCurrent decline from peak | -28.65% | -17.79% | -10.86% |
Average DrawdownAverage peak-to-trough decline | -51.54% | -22.38% | -29.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.32% | 6.34% | +6.98% |
Volatility
THC vs. BMY - Volatility Comparison
Tenet Healthcare Corporation (THC) has a higher volatility of 11.64% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that THC's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THC | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.64% | 8.22% | +3.42% |
Volatility (6M)Calculated over the trailing 6-month period | 28.04% | 18.18% | +9.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.91% | 27.08% | +11.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.34% | 24.02% | +20.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 56.28% | 25.29% | +30.99% |
Dividends
THC vs. BMY - Dividend Comparison
THC has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.38%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
THC Tenet Healthcare Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
THC vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Tenet Healthcare Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
THC vs. BMY - Profitability Comparison
THC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported a gross profit of 3.19B and revenue of 5.37B. Therefore, the gross margin over that period was 59.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
THC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported an operating income of 1.30B and revenue of 5.37B, resulting in an operating margin of 24.1%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
THC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported a net income of 906.00M and revenue of 5.37B, resulting in a net margin of 16.9%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
THC and BMY have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
THC has higher volatility (11.64%) compared to BMY (8.22%). In terms of maximum drawdown, THC dropped -98.28% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.68 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THC and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer